These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18547618

  • 1. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
    Fujii T, Zen Y, Harada K, Niwa H, Masuda S, Kaizaki Y, Watanabe K, Kawashima A, Nakanuma Y.
    Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
    [Abstract] [Full Text] [Related]

  • 2. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H.
    Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
    [Abstract] [Full Text] [Related]

  • 3. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
    Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K, Matsuhashi S.
    Oncogene; 2006 Oct 05; 25(45):6101-12. PubMed ID: 16682950
    [Abstract] [Full Text] [Related]

  • 4. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
    Idobe Y, Murawaki Y, Kitamura Y, Kawasaki H.
    Hepatogastroenterology; 2003 Oct 05; 50(49):54-9. PubMed ID: 12629989
    [Abstract] [Full Text] [Related]

  • 5. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N, Yoshida M, Shibuya A, Sugiura H, Okayasu I, Ohbu M.
    Pathol Int; 2005 Nov 05; 55(11):724-31. PubMed ID: 16271085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of CD44 in human hepatocellular carcinoma cell lines.
    Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M.
    Hepatology; 1995 May 05; 21(5):1276-84. PubMed ID: 7537711
    [Abstract] [Full Text] [Related]

  • 9. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
    Park MY, Kim KR, Park HS, Park BH, Choi HN, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS.
    Int J Oncol; 2007 Dec 05; 31(6):1309-15. PubMed ID: 17982656
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM.
    Tsuchiya A, Kamimura H, Tamura Y, Takamura M, Yamagiwa S, Suda T, Nomoto M, Aoyagi Y.
    Cancer Lett; 2011 Oct 01; 309(1):95-103. PubMed ID: 21669487
    [Abstract] [Full Text] [Related]

  • 12. Significance of CD90+ cancer stem cells in human liver cancer.
    Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST.
    Cancer Cell; 2008 Feb 01; 13(2):153-66. PubMed ID: 18242515
    [Abstract] [Full Text] [Related]

  • 13. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
    Salnikov AV, Kusumawidjaja G, Rausch V, Bruns H, Gross W, Khamidjanov A, Ryschich E, Gebhard MM, Moldenhauer G, Büchler MW, Schemmer P, Herr I.
    Cancer Lett; 2009 Mar 18; 275(2):185-93. PubMed ID: 19026485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pleiotrophin inhibits transforming growth factor beta1-induced apoptosis in hepatoma cell lines.
    Park TJ, Jeong BR, Tateno C, Kim HS, Ogawa T, Lim IK, Yoshizato K.
    Mol Carcinog; 2008 Oct 18; 47(10):784-96. PubMed ID: 18381592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y, Nomura Y, Yoshida M, Hayashi T, Oishi N, Ikeda H, Honda M, Kaneko S.
    J Hepatol; 2014 Jan 18; 60(1):127-34. PubMed ID: 24012616
    [Abstract] [Full Text] [Related]

  • 18. Combined hepatocellular carcinoma and osteoclast-like giant cell tumor of the liver: possible clue to histogenesis.
    Tanahashi C, Nagae H, Nukaya T, Hasegawa M, Yatabe Y.
    Pathol Int; 2009 Nov 18; 59(11):813-6. PubMed ID: 19883433
    [Abstract] [Full Text] [Related]

  • 19. Evidence for cancer stem cells in human endometrial carcinoma.
    Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE.
    Cancer Res; 2009 Nov 01; 69(21):8241-8. PubMed ID: 19843861
    [Abstract] [Full Text] [Related]

  • 20. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P.
    Magy Onkol; 2008 Dec 01; 52(4):379-83. PubMed ID: 19068466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.